Dr. Eric Gavin Feinstein, MD

Dr. Feinstein practices at Urologic Surgery Associates, P.A in Orlando, Florida.

Dr. Feinstein's NPI, 1720340136, was assigned on June 12, 2012. Dr. Feinstein graduated from UVA School of Medicine in 2012. Dr. Feinstein holds Florida license ME136532.

Dr. Feinstein's primary practice is Urologic Surgery Associates, P.A, at 3824 Oakwater Cir, Orlando, FL 32806 in Orange County. The practice phone is (407) 826-8999.

Dr. Feinstein's primary practice is Urologic Surgery Associates, P.A in Orlando, Florida. Dr. Feinstein is also affiliated with AdventHealth Orlando. Dmand AI also links Dr. Feinstein to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Feinstein practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Feinstein's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Feinstein is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Feinstein's licenses on file in 4 states: Florida, Colorado, Illinois and Virginia.

Dmand AI lists age-related macular degeneration, cataract, dry eye, glaucoma, hypertensive retinopathy, inflammation of iris, laser destruction of retinal or choroid lesions and retinal detachment among the conditions Dr. Feinstein treats.

CMS data shows 140,689 Medicare services from Dr. Feinstein across 15 procedure codes in 2024, for 1,198 Medicare patients. Medicare paid $4,741,585 for them.

CMS counts 1,198 Medicare patients who saw Dr. Feinstein in 2024. The largest group is 65 to 74, with 484 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Feinstein's median patient age at 70, with 57% women.

In 2024, Dr. Feinstein wrote 584 Medicare Part D claims for 174 patients. 52% of them were for generic drugs. CMS names the drug for 512 of them, across 9 drugs with 11 or more claims each, at $14,815 in total drug cost. In 2023, CMS named 406 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Feinstein for performance year 2024, reported as part of a group. Dr. Feinstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Feinstein, published from 2012 to 2024. 2015 was the busiest year, with 2. The most frequent topics are Visual Acuity, Tomography, X-Ray Computed and Eye Infections, Bacterial. Dr. Feinstein has published most often in JAMA Ophthalmol. Dr. Feinstein's most frequent co-authors are Hongan Chen, MD, Marc T. Mathias, MD and Pete Setabutr, MD.

CMS Open Payments shows 206 general payments to Dr. Feinstein from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $2,565.

Dr. Feinstein graduated from UVA School of Medicine in 2012.

Dr. Feinstein is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.